Log in

ASX:HSOHealthscope Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume38.30 million shs
Average Volume6.04 million shs
Market Capitalization$4.30 billion
P/E Ratio17.32
Dividend Yield2.86%
BetaN/A
Healthscope Limited provides healthcare services in Australia and New Zealand. The company operates through Hospitals Australia and Pathology New Zealand segments. It operates 43 private hospitals, including 30 acute hospitals, 7 mental health hospitals, and 6 rehabilitation hospitals with approximately 5,000 inpatient beds. The company also provides human pathology services under the Labtests, Southern Community Laboratories, and Northland Pathology brands; and veterinary and analytical pathology services under the Gribbles brand. The company was formerly known as Healthscope Hospitals Holdings Pty. Ltd. and changed its name to Healthscope Limited in July 2014. Healthscope Limited was founded in 1985 and is headquartered in Melbourne, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.1Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.25 out of 5 stars


Industry, Sector and Symbol

Industry Hospitals
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+61-3-99267500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.38 billion
Book ValueA$1.46 per share

Profitability

Miscellaneous

Employees17,100
Outstanding Shares1,748,630,016
Market Cap$4.30 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive HSO News and Ratings via Email

Sign-up to receive the latest news and ratings for HSO and its competitors with MarketBeat's FREE daily newsletter.

Healthscope (ASX:HSO) Frequently Asked Questions

How were Healthscope's earnings last quarter?

Healthscope Ltd (ASX:HSO) posted its quarterly earnings data on Thursday, February, 14th. The company reported $0.04 earnings per share for the quarter. View Healthscope's earnings history.

Has Healthscope been receiving favorable news coverage?

Media stories about HSO stock have been trending positive this week, InfoTrie Sentiment reports. The research firm scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Healthscope earned a news sentiment score of 2.4 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news aboutHealthscope.

Who are some of Healthscope's key competitors?

What other stocks do shareholders of Healthscope own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Healthscope investors own include E Tracs Ubs Blomberg Cmci Energy Etn (UBN), Primary Health Care (PRY) and Fortescue Metals Group (FMG).

Who are Healthscope's key executives?

Healthscope's management team includes the following people:
  • Mr. Gordon Scott Ballantyne, MD, CEO & Director (Age 54)
  • Mr. Michael Sammells, Chief Financial Officer
  • Mr. Mark Briscoe, Gen. Mang. of Operations
  • Mr. David Shirer, Gen. Mang. of Investor Relations
  • Ms. Ingrid A. Player, Group Exec. of Legal, Governance & Sustainability, Gen. Counsel and Sec. (Age 46)

What is Healthscope's stock symbol?

Healthscope trades on the ASX under the ticker symbol "HSO."

How big of a company is Healthscope?

Healthscope has a market capitalization of $0.00 and generates $2.38 billion in revenue each year. Healthscope employs 17,100 workers across the globe.

What is Healthscope's official website?

The official website for Healthscope is www.healthscope.com.au.

How can I contact Healthscope?

Healthscope's mailing address is Level 1, 312 St. Kilda Road, MELBOURNE, VIC 3001, Australia. The company can be reached via phone at +61-3-99267500.

This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.